Zhengye Biotechnology Holding (ZYBT) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T21:04:10.626Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:04:10.626Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2025-12-31: N/A
Quote market capitalization: 52,604,427
Total debt · period ending 2025-12-31: 10,733,865.68
Cash · period ending 2025-12-31: 7,195,462.72

FMP input reference: 148236961db35e193d1d700acaf87b22991c3a1a7f0bfa22e817431605aef681

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

ZYBT EBITDA Yield Metrics

EBITDA YIELD

N/A

ZYBT Competitors' EBITDA Yield

ZYBT

Zhengye Biotechnology Holding Limited

Current

Market Cap

$52.60M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs ZYBT

Market Cap

$52.83M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs ZYBT

Market Cap

$51.99M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMA

ImageneBio Inc

vs ZYBT

Market Cap

$51.88M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs ZYBT

Market Cap

$53.70M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs ZYBT

Market Cap

$51.23M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs ZYBT

Market Cap

$51.19M

EBITDA Yield

N/A

TTM Avg

981.94%

3Y Avg

527.24%

5Y Avg

527.24%

DWTX

Dogwood Therapeutics, Inc.

vs ZYBT

Market Cap

$51.12M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs ZYBT

Market Cap

$54.14M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs ZYBT

Market Cap

$50.28M

EBITDA Yield

11.09%

TTM Avg

20.03%

3Y Avg

16.76%

5Y Avg

21.84%

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Zhengye Biotechnology Holding Limited (ZYBT)	$52.60M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$52.83M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$51.99M	N/A	N/A	N/A	N/A
ImageneBio Inc (IMA)vs ›	$51.88M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$53.70M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.23M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$51.19M	N/A	981.94%	527.24%	527.24%
Dogwood Therapeutics, Inc. (DWTX)vs ›	$51.12M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$54.14M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$50.28M	11.09%	20.03%	16.76%	21.84%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

ZYBT EBITDA Yield Metrics

ZYBT Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics